Suppr超能文献

慢性肾病患者骨组织中铝沉积之谜:一例报告

The enigma of aluminum deposition in bone tissue from a patient with chronic kidney disease: a case report.

作者信息

Meira Rodrigo Dias de, Carbonara Cinthia Esbrile Moraes, Quadros Kélcia Rosana da Silva, Santos Carolina Urbini Dos, Schincariol Patrícia, Pêssoa Gustavo de Souza, Arruda Marco Aurélio Zezzi, Jorgetti Vanda, Oliveira Rodrigo Bueno de

机构信息

Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Medicina Interna, Campinas, SP, Brasil.

Universidade Estadual de Campinas, Departamento de Medicina Interna (Nefrologia) - Faculdade de Ciências Médicas, Laboratório para o Estudo do Distúrbio Mineral e Ósseo em Nefrologia (LEMON), Campinas, SP, Brasil.

出版信息

J Bras Nefrol. 2018 Apr-Jun;40(2):201-205. doi: 10.1590/2175-8239-JBN-3882. Epub 2018 Jun 4.

Abstract

About four decades ago, the relationship between dialysis-dementia and aluminum (Al) began to be established. The restriction of drugs containing Al and improvements on water quality used for dialysis resulted in the clinical disappearance of Al intoxication. However, high prevalence of Al deposition in bone tissue from Brazilian dialysis patients is still being detected. Through the case report of a patient on hemodialysis (HD) for one year, presenting significant Al deposition in bone tissue, we speculated if this problem is not being underestimated. We used extensive investigation to identify potential sources of Al exposure with a careful review of medication history and water quality controls. Al concentration was measured by different methods, including mass spectrometry, in poly-electrolyte concentrate solutions and solution for peritoneal dialysis, in an attempt to elucidate the possible sources of contamination. The objective of this case report is to alert the medical community about a potential high prevalence of Al deposition in bone tissue and to discuss the possible sources of contamination in patients with chronic kidney disease (CKD).

摘要

大约四十年前,透析性痴呆与铝(Al)之间的关系开始被确立。限制含铝药物以及改善透析用水质量导致了铝中毒在临床上的消失。然而,巴西透析患者骨组织中铝沉积的高发生率仍被检测到。通过对一名接受血液透析(HD)一年且骨组织中有大量铝沉积的患者的病例报告,我们推测这个问题是否未被低估。我们进行了广泛调查,通过仔细回顾用药史和水质控制来确定铝暴露的潜在来源。采用不同方法测量了聚电解质浓缩液和腹膜透析液中的铝浓度,包括质谱法,以试图阐明可能的污染来源。本病例报告的目的是提醒医学界注意骨组织中铝沉积可能存在的高发生率,并讨论慢性肾脏病(CKD)患者中可能的污染来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f67/6533990/4f0bbbd75232/2175-8239-jbn-3882-gf01.jpg

相似文献

2
Bone aluminum accumulation in the current era.当前时代的骨铝蓄积。
J Bras Nefrol. 2024 Apr 29;46(3):e20240023. doi: 10.1590/2175-8239-JBN-2024-0023en. eCollection 2024.
7
Aluminum toxicokinetics in peritoneal dialysis patients.腹膜透析患者体内的铝毒代动力学。
Clin Toxicol (Phila). 2011 Aug;49(7):659-63. doi: 10.3109/15563650.2011.602083. Epub 2011 Aug 8.

引用本文的文献

1
Bone aluminum accumulation in the current era.当前时代的骨铝蓄积。
J Bras Nefrol. 2024 Apr 29;46(3):e20240023. doi: 10.1590/2175-8239-JBN-2024-0023en. eCollection 2024.
3
Aluminum Intoxication in Chronic Kidney Disease.慢性肾脏病中的铝中毒
J Bras Nefrol. 2021 Dec 3;43(4 Suppl 1):660-664. doi: 10.1590/2175-8239-JBN-2021-S110. eCollection 2021.

本文引用的文献

5
Serum concentrations of aluminum in hemodialysis patients.血液透析患者的血清铝浓度。
Am J Kidney Dis. 2011 Mar;57(3):523-5. doi: 10.1053/j.ajkd.2010.10.051. Epub 2011 Jan 22.
6
Drugs as a hidden source of aluminium for chronic renal patients.药物作为慢性肾病患者铝的隐匿来源。
Nephrol Dial Transplant. 2007 Feb;22(2):605-11. doi: 10.1093/ndt/gfl569. Epub 2006 Oct 11.
9
Aluminium and bone disease in chronic renal failure.慢性肾衰竭中的铝与骨病
Nephrol Dial Transplant. 2002;17 Suppl 2:21-4. doi: 10.1093/ndt/17.suppl_2.21.
10
Intestinal absorption of aluminium in renal failure.肾衰竭时铝的肠道吸收
Nephrol Dial Transplant. 2002;17 Suppl 2:13-6. doi: 10.1093/ndt/17.suppl_2.13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验